In CRC, p53 enhances the expression of carboxymethylene butenolide homolog (CMBL), which destabilizes phosphofructokinase platelet-type (PFKP), a rate-limiting glycolytic enzyme. The gene discussed is TP53; the disease is colorectal carcinoma.